Spellman Introduces X-Ray Sub-Systems for Industrial NDT, Security and Medical Applications

Spellman High Voltage Electronics Corporation, the world's leading manufacturer of custom high voltage power conversion products, introduces X-Ray sub-systems, featuring its industry leading XRV high voltage generators, available in unipolar and bipolar, 160 to 450kV, 1.8-6kW.

By combining  the robust XRV generator with industry leading Metal Ceramic X-Ray tubes, tube coolers/chillers and HV cables, Spellman provides a flexible, cost effective solution for many applications.

Customers select cable lengths and standard or spring loaded connectors to integrate the generator, X-Ray tube, digital touch screen controller, I/O box, cooler and all other accessories, providing a "plug and play" X-Ray sub-system.

Spellman's XRV generators, used by OEMs and X-Ray integrators around the world, are the most compact and lightest available in the market. Featuring superior stability, low ripple, integrated dual filament supplies, digital interface, comprehensive fault diagnostics and protection circuitry, the XRV series has become the generator of choice in CR, DR and Industrial CT applications. The XRV datasheet can be downloaded here:

http://www.spellmanhv.com/en/Products/Industrial-X-Ray-Products/Industrial-X-Ray-Generators/XRV.aspx

To learn more about XRV X-Ray sources and their many benefits and features contact Spellman's applications support staff at 631-630-3000.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.